Skip to content

Clinical trials

Completed Phase 2 Glaucoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glaucoma Phase: Phase 2 Status: Completed Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20052
20062
20074
20081
20096
20105
20116
20124
20136
20148
20153
20162
20171
20181
20191
20201
20214
20221
20231
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aerie Pharmaceuticals9
Alcon Research9
Mati Therapeutics Inc.7
Qlaris Bio, Inc.6
Allergan4
Santen Inc.4
Amakem, NV2
Hoffmann-La Roche2
Inotek Pharmaceuticals Corporation2
Sylentis, S.A.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glaucoma70
Ocular Hypertension49
Glaucoma, Open-Angle32
Hypertension6
Eye Diseases3
Low Tension Glaucoma2
Sturge-Weber Syndrome2
Cataract1
Glaucoma, Angle-Closure1
Glaucoma, Neovascular1

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.